Literature DB >> 27122913

Interventional Transcatheter Closure Ameliorates the Leukocyte Rho Kinase Activities among Patients with Patent Ductus Arteriosus.

Min-Ling Hsieh1, Ping-Yen Liu2, Jing-Ming Wu1, James K Liao3, Jieh-Neng Wang1.   

Abstract

BACKGROUND: Patent ductus arteriosus (PDA) causes increased pulmonary blood flow, which can lead to pulmonary arterial hypertension (PAH). Rho-associated coiled-coil containing protein kinase (ROCK) may play an important pathophysiological role in PAH. We hypothesized that the increased pulmonary artery (PA) flow from PDA could activate ROCK.
METHODS: Patients who received a PDA transcatheter closure in our hospital were consecutively enrolled in this study. Basic demographics and clinical hemodynamic data of the study participants were recorded. Then, ROCK activity was measured before and after the PDA occlusion procedure. ROCK activity was defined as the phosphorylation ratio of myosin-binding subunit by Western blot measurement. We also sub-divided patients into the coil group and occluder group based on the occlusion device used in each patient's procedure.
RESULTS: From January 2009 to December 2011, 25 patients with a median age of 2.3 years, ranging from 10 months to 72 years were enrolled. The mean PDA size was 0.31 ± 0.14 cm, the mean Qp/Qs shunt was 1.54 ± 0.41, and the mean systolic pulmonary artery pressure was 26.9 ± 10.3 mmHg. There were 10 patients (one boy and nine girls) in the coil group and 15 patients (four boys and eleven girls) in the occluder group. Following the closure of the PDA, ROCK activity significantly decreased (1.78 ± 2.25 vs. 0.77 ± 0.69, p < 0.01). There was a strong correlation between the leukocyte ROCK activity with the systolic PA pressure (y = 5.4608x + 22.54, R2 = 0.5539, p < 0.05), but not the Qp/Qs value. Both subgroups showed significant changes of ROCK activity after the procedure. Interestingly, when comparing the coil group with the occluder group, the decrease in ROCK activity was more apparent in the occluder group.
CONCLUSIONS: The findings of this study indicated that ROCK activity is higher in patients with PDA and correlates with PA pressure. The decrease in ROCK activity following the device closure suggests that ROCK may be an important biomarker for PDA patency. KEY WORDS: Patent ductus arteriosus (PDA); Pulmonary arterial pressure; Rho kinase; Transcatheter closure.

Entities:  

Year:  2015        PMID: 27122913      PMCID: PMC4804973          DOI: 10.6515/acs20150424d

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  35 in total

Review 1.  Regulation and functions of Rho-associated kinase.

Authors:  M Amano; Y Fukata; K Kaibuchi
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

Review 2.  Rho family-associated kinases PAK1 and rock.

Authors:  Hiroshi Maruta; Thao V Nheu; Hong He; Yumiko Hirokawa
Journal:  Prog Cell Cycle Res       Date:  2003

Review 3.  Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response.

Authors:  Eleni Tzima
Journal:  Circ Res       Date:  2006-02-03       Impact factor: 17.367

4.  Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.

Authors:  Fu-Hai Li; Wei Xia; Ai-Wu Li; Cui-Fen Zhao; Ruo-Peng Sun
Journal:  Chin Med J (Engl)       Date:  2007-01-05       Impact factor: 2.628

5.  Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.

Authors:  Gary Peng; Julijana Ivanovska; Crystal Kantores; Todd Van Vliet; Doreen Engelberts; Brian P Kavanagh; Masahiro Enomoto; Jaques Belik; Amish Jain; Patrick J McNamara; Robert P Jankov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

6.  Transcatheter closure of moderate to large patent ductus arteriosus with the Amplatzer duct occluder.

Authors:  Jou-Kou Wang; Mei-Hwan Wu; Juey-Jen Hwang; Fu-Tein Chiang; Ming-Tai Lin; Hung-Chi Lue
Journal:  Catheter Cardiovasc Interv       Date:  2007-03-01       Impact factor: 2.692

7.  Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.

Authors:  Fuhai Li; Wei Xia; Aiwu Li; Cuifen Zhao; Ruopeng Sun
Journal:  Pharmacol Res       Date:  2006-11-01       Impact factor: 7.658

8.  Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells.

Authors:  Xiu-Fen Ming; Hema Viswambharan; Christine Barandier; Jean Ruffieux; Kozo Kaibuchi; Sandro Rusconi; Zhihong Yang
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

9.  Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Authors:  Masao Takemoto; Jianxin Sun; Junko Hiroki; Hiroaki Shimokawa; James K Liao
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

Review 10.  Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus.

Authors:  E K Weir; M Obreztchikova; A Vargese; J A Cabrera; D A Peterson; Z Hong
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.